About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

I'rom Group Co.,Ltd.(2372) Summary

2372
TSE Prime
I'rom Group Co.,Ltd.
2,791
JPY
+4
(+0.14%)
Apr 10, 3:30 pm JST
19.01
USD
Apr 10, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
2.58
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 10, 2025
Opening Apr 10, 9:00 am
2,789 JPY 18.92 USD
Previous Close Apr 9
2,787 JPY 19.17 USD
High Apr 10, 2:28 pm
2,791 JPY 19.05 USD
Low Apr 10, 10:39 am
2,787 JPY 18.92 USD
Volume
19,500
Trading Value
0.05B JPY 0.37M USD
VWAP
2788.11 JPY 19.0 USD
Minimum Trading Value
279,100 JPY 1,901 USD
Market Cap
0.03T JPY 0.24B USD
Number of Trades
60
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
Mid
1-Year Average
122
1-Year High May 16, 2024
1,918
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 0 5,600
Mar 28, 2025 0 26,300
Mar 21, 2025 0 7,800
Mar 14, 2025 0 7,100
Mar 7, 2025 0 9,500
Company Profile
I'rom Group Co., Ltd. primarily focuses on supporting clinical trials for medical institutions. The company also engages in contract pharmaceutical development and clinic mall operations.
Sector
Services
I'rom Group Co., Ltd. operates broadly in the medical field, centering on SMO (Site Management Organization) services, while also providing CRO (Contract Research Organization) services, advanced medical care, drug discovery, and medical support services. In its SMO business, the company contracts and supports clinical trial operations from medical institutions. The CRO division conducts early-stage clinical trials, supporting global development for pharmaceutical companies. The advanced medical care division develops vaccines and gene therapy products using vector technology, conducts research and development in regenerative medicine, and offers contract manufacturing of clinical vectors. In drug discovery, I'rom Group collaborates on developing biosimilars and other pharmaceuticals. The medical support division operates clinic malls and provides medical business consulting services.